TSVT Financial Statements

Balance sheet, income statement, cash flow, and dividends for 2seventy Bio Inc (TSVT).


$151.67M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

TSVT Market Cap. (MRY)


TSVT Shares Outstanding (MRY)


TSVT Assets (MRY)


Total Assets

$479.51M

Total Liabilities

$268.70M

Total Investments

$151.73M

TSVT Income (MRY)


Revenue

$37.86M

Net Income

-$57.25M

Operating Expense

$137.70M

TSVT Cash Flow (MRY)


CF Operations

-$85.00M

CF Investing

$80.76M

CF Financing

$417.00K

TSVT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

TSVT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$479,510,000 (-15.19%)

$565,426,000 (-13.89%)

$656,665,000 (-13.56%)

$759,675,000 (143.00%)

Assets Current

$187,256,000 (-21.24%)

$237,765,000 (-20.98%)

$300,882,000 (3.20%)

$291,564,000 (1061.42%)

Assets Non-Current

$292,254,000 (-10.81%)

$327,661,000 (-7.90%)

$355,783,000 (-24.00%)

$468,111,000 (62.81%)

Goodwill & Intangible Assets

$5,885,000 (-10.75%)

$6,594,000 (-65.94%)

$19,358,000 (-11.80%)

$21,948,000 (16.92%)

Shareholders Equity

$210,806,000 (-17.43%)

$255,300,000 (-17.77%)

$310,466,000 (-13.72%)

$359,822,000 (382.15%)

Property Plant & Equipment Net

$238,150,000 (-14.37%)

$278,108,000 (-6.24%)

$296,620,000 (-4.45%)

$310,447,000 (19.18%)

Cash & Equivalents

$71,244,000 (-4.95%)

$74,958,000 (5.53%)

$71,032,000 (-45.53%)

$130,414,000 (0%)

Accumulated Other Comprehensive Income

$89,000 (143.63%)

-$204,000 (92.91%)

-$2,877,000 (-304.07%)

-$712,000 (0%)

Deferred Revenue

$0 (0%)

$19,321,000 (141.51%)

$8,000,000 (-73.99%)

$30,762,000 (15.72%)

Total Investments

$151,729,000 (-17.98%)

$184,990,000 (-21.30%)

$235,043,000 (1.41%)

$231,767,000 (0%)

Investments Current

$103,510,000 (-27.12%)

$142,031,000 (-27.25%)

$195,238,000 (45.00%)

$134,643,000 (0%)

Investments Non-Current

$48,219,000 (12.24%)

$42,959,000 (7.92%)

$39,805,000 (-59.02%)

$97,124,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$7,781,000 (-41.98%)

$13,411,000 (-36.02%)

$20,960,000 (23.33%)

$16,995,000 (58.97%)

Trade & Non-Trade Payables

$1,055,000 (-82.50%)

$6,028,000 (-16.37%)

$7,208,000 (19.65%)

$6,024,000 (-15.77%)

Accumulated Retained Earnings (Deficit)

-$568,464,000 (-11.20%)

-$511,217,000 (-74.09%)

-$293,647,000 (-643.52%)

-$39,494,000 (0%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$243,717,000 (-5.05%)

$256,673,000 (-5.00%)

$270,172,000 (-4.27%)

$282,215,000 (121.17%)

Debt Current

$16,365,000 (29.27%)

$12,660,000 (13.40%)

$11,164,000 (14.28%)

$9,769,000 (-36.20%)

Debt Non-Current

$227,352,000 (-6.83%)

$244,013,000 (-5.79%)

$259,008,000 (-4.93%)

$272,446,000 (142.63%)

Total Liabilities

$268,704,000 (-13.36%)

$310,126,000 (-10.42%)

$346,199,000 (-13.42%)

$399,853,000 (68.01%)

Liabilities Current

$40,092,000 (-32.93%)

$59,779,000 (-25.08%)

$79,794,000 (-18.90%)

$98,388,000 (29.68%)

Liabilities Non-Current

$228,612,000 (-8.68%)

$250,347,000 (-6.03%)

$266,405,000 (-11.63%)

$301,465,000 (85.95%)

TSVT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$37,862,000 (-62.28%)

$100,387,000 (9.72%)

$91,496,000 (67.81%)

$54,522,000 (-78.03%)

Cost of Revenue

$18,010,000 (6.45%)

$16,918,000 (2.06%)

$16,577,000 (40.04%)

$11,837,000 (119.37%)

Selling General & Administrative Expense

$43,924,000 (-36.72%)

$69,414,000 (-12.63%)

$79,450,000 (-15.03%)

$93,506,000 (2.87%)

Research & Development Expense

$76,917,000 (-66.67%)

$230,758,000 (-7.23%)

$248,735,000 (-1.54%)

$252,617,000 (-14.79%)

Operating Expenses

$137,697,000 (-57.08%)

$320,842,000 (-5.03%)

$337,827,000 (-5.16%)

$356,194,000 (-8.05%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$57,247,000 (73.69%)

-$217,570,000 (14.39%)

-$254,153,000 (13.02%)

-$292,213,000 (-143.28%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$57,247,000 (73.69%)

-$217,570,000 (14.39%)

-$254,153,000 (13.02%)

-$292,213,000 (-143.28%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$57,247,000 (73.69%)

-$217,570,000 (14.39%)

-$254,153,000 (13.02%)

-$292,213,000 (-143.28%)

Weighted Average Shares

$52,218,000 (5.97%)

$49,276,000 (38.27%)

$35,637,000 (51.65%)

$23,499,000 (0.56%)

Weighted Average Shares Diluted

$52,218,000 (5.97%)

$49,276,000 (38.27%)

$35,637,000 (51.65%)

$23,499,000 (0.56%)

Earning Before Interest & Taxes (EBIT)

-$57,247,000 (73.69%)

-$217,570,000 (14.39%)

-$254,153,000 (13.02%)

-$292,213,000 (-143.28%)

Gross Profit

$19,852,000 (-76.22%)

$83,469,000 (11.41%)

$74,919,000 (75.52%)

$42,685,000 (-82.41%)

Operating Income

-$117,845,000 (50.35%)

-$237,373,000 (9.71%)

-$262,908,000 (16.14%)

-$313,509,000 (-116.75%)

TSVT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$80,763,000 (84.13%)

$43,861,000 (274.98%)

$11,697,000 (-24.10%)

$15,411,000 (169.23%)

Net Cash Flow from Financing

$417,000 (-99.67%)

$127,390,000 (-23.36%)

$166,229,000 (-53.16%)

$354,889,000 (294.08%)

Net Cash Flow from Operations

-$84,998,000 (49.06%)

-$166,858,000 (29.64%)

-$237,134,000 (-14.54%)

-$207,034,000 (-205.39%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,818,000 (-186.91%)

$4,393,000 (107.42%)

-$59,208,000 (-136.26%)

$163,266,000 (0%)

Net Cash Flow - Business Acquisitions and Disposals

$43,000,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$38,294,000 (-33.66%)

$57,726,000 (67.13%)

$34,539,000 (-1.28%)

$34,986,000 (0%)

Capital Expenditure

-$531,000 (96.17%)

-$13,865,000 (39.30%)

-$22,842,000 (-97.34%)

-$11,575,000 (48.00%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$417,000 (-99.67%)

$127,390,000 (-23.36%)

$166,229,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$12,150,000 (-62.22%)

$32,159,000 (-21.64%)

$41,040,000 (-24.88%)

$54,629,000 (-10.44%)

Depreciation Amortization & Accretion

$7,096,000 (-31.01%)

$10,285,000 (-10.82%)

$11,533,000 (-29.46%)

$16,350,000 (23.98%)

TSVT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

52.40% (-36.94%)

83.10% (1.47%)

81.90% (4.60%)

78.30% (-19.94%)

Profit Margin

-151.20% (30.23%)

-216.70% (21.99%)

-277.80% (48.17%)

-536.00% (-1007.44%)

EBITDA Margin

-132.50% (35.84%)

-206.50% (22.13%)

-265.20% (47.59%)

-506.00% (-1074.01%)

Return on Average Equity (ROAE)

-26.00% (60.24%)

-65.40% (6.03%)

-69.60% (48.25%)

-134.50% (33.74%)

Return on Average Assets (ROAA)

-11.40% (65.24%)

-32.80% (2.96%)

-33.80% (37.98%)

-54.50% (-42.30%)

Return on Sales (ROS)

-151.20% (30.23%)

-216.70% (21.99%)

-277.80% (48.17%)

-536.00% (-1007.44%)

Return on Invested Capital (ROIC)

-9.20% (69.13%)

-29.80% (14.37%)

-34.80% (32.30%)

-51.40% (-42.78%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.67 (-176.71%)

-0.97 (26.48%)

-1.31 (36.21%)

-2.06

Price to Sales Ratio (P/S)

4.05 (93.46%)

2.1 (-42.58%)

3.65 (-66.96%)

11.05

Price to Book Ratio (P/B)

0.72 (-15.11%)

0.85 (-25.96%)

1.14 (-31.29%)

1.67

Debt to Equity Ratio (D/E)

1.27 (4.94%)

1.22 (8.97%)

1.11 (0.36%)

1.11 (-65.16%)

Earnings Per Share (EPS)

-1.1 (75.11%)

-4.42 (38.01%)

-7.13 (42.68%)

-12.44 (-142.02%)

Sales Per Share (SPS)

0.72 (-64.41%)

2.04 (-20.65%)

2.57 (10.65%)

2.32 (-78.15%)

Free Cash Flow Per Share (FCFPS)

-1.64 (55.34%)

-3.67 (49.72%)

-7.29 (21.58%)

-9.3 (-141.39%)

Book Value Per Share (BVPS)

4.04 (-22.08%)

5.18 (-40.53%)

8.71 (-43.10%)

15.31 (379.40%)

Tangible Assets Book Value Per Share (TABVPS)

9.07 (-20.02%)

11.34 (-36.58%)

17.88 (-43.04%)

31.39 (149.67%)

Enterprise Value Over EBIT (EV/EBIT)

-6 (-200.00%)

-2 (0.00%)

-2 (0.00%)

-2

Enterprise Value Over EBITDA (EV/EBITDA)

-6.76 (-262.96%)

-1.86 (9.87%)

-2.07 (20.07%)

-2.59

Asset Turnover

0.07 (-50.33%)

0.15 (23.77%)

0.12 (19.61%)

0.1 (-87.10%)

Current Ratio

4.67 (17.45%)

3.98 (5.46%)

3.77 (27.27%)

2.96 (795.17%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$85,529,000 (52.67%)

-$180,723,000 (30.48%)

-$259,976,000 (-18.92%)

-$218,609,000 (-142.75%)

Enterprise Value (EV)

$339,131,955 (-12.16%)

$386,098,068 (-23.02%)

$501,546,413 (-29.68%)

$713,248,725

Earnings Before Tax (EBT)

-$57,247,000 (73.69%)

-$217,570,000 (14.39%)

-$254,153,000 (13.02%)

-$292,213,000 (-143.28%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$50,151,000 (75.81%)

-$207,285,000 (14.56%)

-$242,620,000 (12.05%)

-$275,863,000 (-157.99%)

Invested Capital

$606,006,000 (-10.98%)

$680,768,000 (-10.03%)

$756,653,000 (-4.36%)

$791,140,000 (128.93%)

Working Capital

$147,164,000 (-17.32%)

$177,986,000 (-19.50%)

$221,088,000 (14.45%)

$193,176,000 (480.54%)

Tangible Asset Value

$473,625,000 (-15.25%)

$558,832,000 (-12.31%)

$637,307,000 (-13.61%)

$737,727,000 (151.06%)

Market Capitalization

$151,669,955 (-29.84%)

$216,167,068 (-39.16%)

$355,279,413 (-40.68%)

$598,949,725

Average Equity

$220,287,750 (-33.77%)

$332,635,250 (-8.87%)

$365,011,500 (68.03%)

$217,225,500 (267.18%)

Average Assets

$503,075,750 (-24.19%)

$663,595,500 (-11.66%)

$751,184,000 (40.11%)

$536,147,500 (70.86%)

Invested Capital Average

$622,913,000 (-14.78%)

$730,944,750 (0.10%)

$730,231,500 (28.48%)

$568,361,500 (70.12%)

Shares

51,588,420 (1.90%)

50,624,606 (33.52%)

37,916,693 (62.25%)

23,369,088 (0.35%)